Treatment of Schizophrenia Through Internet-Based Psychoeducation - Full Text View

Sponsor:	National Institute of Mental Health (NIMH)
Information provided by:	National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:	NCT00051233

Purpose

The purpose of this study is to assess the effectiveness of a Web-based psychoeducational program in helping people with schizophrenia and their families manage the disease.

Condition	Intervention	Phase
Schizophrenia Schizoaffective Disorder	Procedure: World Wide Web-Based Psychoeducation	Phase II

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title:	Schizophrenia Patient and Family Continuity of Care

Resource links provided by NLM:

MedlinePlus related topics: Schizophrenia

U.S. FDA Resources

Further study details as provided by National Institute of Mental Health (NIMH):

Estimated Enrollment:	40
Study Start Date:	January 2003
Estimated Study Completion Date:	January 2005

Detailed Description:

This study will provide a comprehensive psychoeducational program which includes education, social support, information, coping strategies, and guidance from mental health, social services, and medical professionals. This study will work to reduce relapse, facilitate patient rehabilitation, decrease family distress, and improve family well being.

Patients and their families participate in an in-person Psychoeducational Survival Skills Workshop that is designed to provide patients and their families with basic information about schizophrenia and its treatment. After the workshop, participants are provided with 6 Web-based modules that are designed to increase mental health and schizophrenia knowledge. Patient relapse, family distress, family knowledge of schizophrenia, and data on user's acceptance and utilization are measured to determine the intervention's effectiveness.

Eligibility

Ages Eligible for Study:	14 Years to 55 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria

DSM-IV diagnosis of schizophrenia or schizoaffective disorder
At least 4 hours/week in-person contact with a family member
Primary caregiver with a telephone
Patient and primary caregiver speak and read English

Exclusion Criteria:

Enrolled in another clinical trial
Evidence of organic brain syndrome
Current alcohol or substance abuse that could explain the presenting index psychotic episode
DSM-IV diagnosis of psychoactive substance dependency

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00051233

Locations

United States, Pennsylvania
University of Pittsburgh Western Psychiatric Institute and Clinic
Pittsburgh, Pennsylvania, United States, 15261

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

Investigators

Principal Investigator:

Armando J Rotondi

University of Pittsburgh

More Information

No publications provided

Study ID Numbers:	R01 MH63484, DSIR SE-DR
Study First Received:	January 7, 2003
Last Updated:	November 17, 2005
ClinicalTrials.gov Identifier:	NCT00051233 History of Changes
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Schizophrenia
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on November 27, 2009